Andrew Bulmer is a biomedical scientist and graduated with his PhD from the University of Queensland, Australia in 2008. Since then Dr Bulmer has developed the 'Experimental Laboratory Science' research group within the School of Medical Science at Griffith University. His group is focussed on understanding the impact of injury and inflammation within veins and arteries. The XLabS group uses a variety of approaches including ultrasound and clinical biochemistry and haematology approaches to determine the impact that different vascular access procedures and devices have on thrombosis and the duration of vascular device patency.
Monday, October 7
8:45 AM – 9:45 AM